Back to search

Article

Trilobatin attenuates blood-brain barrier dysfunction induced by cerebral ischemia reperfusion by targeting MMP9: Involvement of APOE4/CypA/NF-κB signaling

2022-09-24

Abstract excerpt

<h4>Background: </h4> and Purpose: Blood-brain barrier (BBB) breakdown is one of the most crucial pathological changes of cerebral ischemia-reperfusion (I/R) injury. Trilobatin (TLB), a naturally occurring food additive, exerts neuroprotective effect against cerebral I/R injury as demonstrated in our previous study. This study was designed to investigate the effect of TLB on disruption of BBB after cerebral I/R in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a9f46f3-adcc-5196-bab0-5b136210fea8
DOI
10.22541/au.166401583.31157691/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Trilobatin attenuates blood-brain barrier dysfunction induced by cerebral ischemia reperfusion by targeting MMP9: Involvement of APOE4/CypA/NF-κB signalingDOI 10.22541/au.166401583.31157691/v1
Select a neighboring publication to make it the new centre.